$55M equity rights offering
Company: Core Scientific
What the later record shows
Delivered; the record does not say when
A May 2024 filing confirms the rights offering commenced on November 20, 2023 and refers to common stock issued under it, so it appears to have been carried out. No passage states the amount raised or when it closed, so the $55M figure and timing are unconfirmed.
“On November 20, 2023, the Company commenced the Equity Rights Offering.”
2024-05-05 · Core Scientific 424B3 filed 2024-05-06 View cached copy (2026-08-31)Live source ↗
“each holder of Old Common Interests as of the rights offering record date was entitled to a Subscription Right to purchase up to its pro rata allocation”
2024-05-05 · Core Scientific 424B3 filed 2024-05-06 View cached copy (2026-08-31)Live source ↗
Checked November 17, 2026 against filings, releases and reporting published after the claim was made. Quotes are verbatim from the linked documents.
The claim, verbatim
Core Scientific began a rights offering of up to $55 million. Holders of Existing Common Interests as of the November 16, 2023 record date can buy their pro rata share of reorganized Core Scientific stock. The offering expires at 5:00pm New York City time on December 11, 2023.
Source (primary)
core-scientific 8-K exhibit (d909892dex991.htm) (SEC EDGAR (8-K Ex), press_release)
View cached copy (2026-11-16)Live source ↗
Quote: “The Rights Offering commenced on November 20, 2023. • The Rights Offering expires at 5:00pm, New York City Time, on December 11, 2023.”
How we checked this
This claim has not yet been checked assertion-by-assertion against its source. It carries a cited source and quote, but the deeper check has not run. When it does, the result appears here whatever it says.
Additional evidence
confirms core-scientific 8-K exhibit (d909892dex991.htm)
Quote: “The Rights Offering commenced on November 20, 2023. • The Rights Offering expires at 5:00pm, New York City Time, on December 11, 2023.”
confirms Core Scientific 424B3 filed 2024-05-06
Quote: “On November 20, 2023, the Company commenced the Equity Rights Offering.”